About the Authors
- Alessia Lodi
-
Contributed equally to this work with: Alessia Lodi, Stefano Tiziani
* E-mail: alessia@austin.utexas.edu (AL); m.t.drayson@bham.ac.uk (MTD)
Affiliations School of Cancer Sciences, The University of Birmingham, Birmingham, United Kingdom, Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, United States of America
- Stefano Tiziani
-
Contributed equally to this work with: Alessia Lodi, Stefano Tiziani
Affiliations School of Cancer Sciences, The University of Birmingham, Birmingham, United Kingdom, Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, United States of America, Dell Pediatric Research Institute, The University of Texas at Austin, Austin, Texas, United States of America
- Farhat L. Khanim
-
Affiliation School of Biosciences, The University of Birmingham, Birmingham, United Kingdom
- Ulrich L. Günther
-
Affiliation School of Cancer Sciences, The University of Birmingham, Birmingham, United Kingdom
- Mark R. Viant
-
Affiliation School of Biosciences, The University of Birmingham, Birmingham, United Kingdom
- Gareth J. Morgan
-
Affiliation Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, United Kingdom
- Christopher M. Bunce
-
Affiliation School of Biosciences, The University of Birmingham, Birmingham, United Kingdom
- Mark T. Drayson
-
* E-mail: alessia@austin.utexas.edu (AL); m.t.drayson@bham.ac.uk (MTD)
Affiliation School of Immunity and Infection, The University of Birmingham, Birmingham, United Kingdom
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Clinical lead on Myeloma IX: GJM. Clinical investigator on Myeloma IX: MTD. Conceived and designed the experiments: AL ST FLK ULG MRV GJM CMB MTD. Performed the experiments: AL ST. Analyzed the data: AL ST FLK ULG MRV GJM CMB MTD. Contributed reagents/materials/analysis tools: ULG MRV GJM CMB MTD. Wrote the paper: AL ST FLK ULG MRV GJM CMB MTD.